| 1. Executive Summary |
| 2. Global Peripheral Vascular Disease (PVD) Diagnostics Market Introduction |
| 2.1. Global Peripheral Vascular Disease (PVD) Diagnostics Market – Taxonomy |
| 2.2. Global Peripheral Vascular Disease (PVD) Diagnostics Market –Definitions |
| 2.2.1. By Diagnosis Type |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3. Global Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Peripheral Vascular Disease (PVD) Diagnostics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Peripheral Vascular Disease (PVD) Diagnostics Market – Competition Landscape |
| 4. Global Peripheral Vascular Disease (PVD) Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Peripheral Vascular Disease (PVD) Diagnostics Market, By Diagnosis Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Ankle-brachial index (ABI) |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Doppler Ultrasound |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Angiography |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Peripheral Vascular Disease (PVD) Diagnostics Market Forecast, By End User, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 6.1. Hospitals & Diagnostic Labs |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Surgical Centers |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Peripheral Vascular Disease (PVD) Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Region, 2022-2028 |
| 8. North America Peripheral Vascular Disease (PVD) Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Ankle-brachial index (ABI) |
| 8.1.2. Doppler Ultrasound |
| 8.1.3. Angiography |
| 8.1.4. Others |
| 8.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Hospitals & Diagnostic Labs |
| 8.2.2. Ambulatory Surgical Centers |
| 8.2.3. Others |
| 8.3. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
| 8.5. North America Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
| 9. Europe Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Ankle-brachial index (ABI) |
| 9.1.2. Doppler Ultrasound |
| 9.1.3. Angiography |
| 9.1.4. Others |
| 9.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Hospitals & Diagnostic Labs |
| 9.2.2. Ambulatory Surgical Centers |
| 9.2.3. Others |
| 9.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Poland |
| 9.3.8. Rest of Europe |
| 9.4. Europe Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
| 9.5. Europe Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
| 10. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Ankle-brachial index (ABI) |
| 10.1.2. Doppler Ultrasound |
| 10.1.3. Angiography |
| 10.1.4. Others |
| 10.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Hospitals & Diagnostic Labs |
| 10.2.2. Ambulatory Surgical Centers |
| 10.2.3. Others |
| 10.3. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
| 10.5. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
| 11. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Ankle-brachial index (ABI) |
| 11.1.2. Doppler Ultrasound |
| 11.1.3. Angiography |
| 11.1.4. Others |
| 11.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Hospitals & Diagnostic Labs |
| 11.2.2. Ambulatory Surgical Centers |
| 11.2.3. Others |
| 11.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
| 11.5. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
| 12. Middle East and Africa Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Ankle-brachial index (ABI) |
| 12.1.2. Doppler Ultrasound |
| 12.1.3. Angiography |
| 12.1.4. Others |
| 12.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Hospitals & Diagnostic Labs |
| 12.2.2. Ambulatory Surgical Centers |
| 12.2.3. Others |
| 12.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
| 12.5. MEA Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Diagnostics & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Arjo AB |
| 13.2.2. D. E. Hokanson Inc |
| 13.2.3. Fukuda Denshi Co. Ltd |
| 13.2.4. Koven Technology Inc |
| 13.2.5. Perimed AB |
| 13.2.6. Unetixs Vascular Inc |
| 13.2.7. Viasonix Ltd. |
| 13.2.8. BiomediX |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
hghLatin America Got Significant Share
Peripheral Vascular Disease Pvd Diagnostics Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Arjo AB
- E. Hokanson Inc
- Fukuda Denshi Co. Ltd
- Koven Technology Inc
- Perimed AB
- Unetixs Vascular Inc
- Viasonix Ltd.
- BiomediX